Generic Drugs EGFR Inhibitor Dacomitinib 45mg

Dacomitinib is an EGFR inhibitor. It’s used for NSCLC patients who have certain gene changes. It goes after the EGFR exon 19 deletion or the L858R mutations in exon 21.

You can get it in 15, 30, or 45 mg doses, all in those film-coated tablet things. For adults, the usual dose is 45 mg a day. One bottle has 30 of the 45 mg tablets, so it’s a full month’s worth at the recommended dose.

Dacomitinib works by stopping EGFR signaling, which is super important for cancer growth and survival. Keep an eye out for side effects, and make sure you’re taking this stuff under a doc’s watch.